Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report

被引:1770
作者
Malfertheiner, Peter [1 ]
Megraud, Francis [2 ]
O'Morain, Colm A. [3 ]
Atherton, John [4 ]
Axon, Anthony T. R. [5 ]
Bazzoli, Franco [6 ]
Gensini, Gian Franco [8 ]
Gisbert, Javier P. [9 ]
Graham, David Y. [10 ]
Rokkas, Theodore [11 ]
El-Omar, Emad M. [7 ]
Kuipers, Ernst J. [12 ]
机构
[1] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany
[2] Univ Bordeaux 2, Dept Bacteriol, INSERM, U853, F-33076 Bordeaux, France
[3] Trinity Coll Dublin, Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland
[4] Univ Nottingham, Sch Clin Sci, Nottingham, England
[5] Spire Leeds Hosp, Leeds, W Yorkshire, England
[6] Univ Bologna, Bologna, Italy
[7] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland
[8] Univ Florence, Florence, Italy
[9] Hosp Univ Princesa, IP & CIBEREHD, Madrid, Spain
[10] VA Med Ctr Houston, Houston, TX USA
[11] Henry Dunant Hosp, Dept Gastroenterol, Athens, Greece
[12] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands
关键词
PROTON-PUMP INHIBITOR; DIFFUSE GASTRIC-CANCER; C-13-UREA BREATH TEST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACID-SUPPRESSIVE THERAPY; PEPTIC-ULCER DISEASE; STOOL ANTIGEN TEST; TERM-FOLLOW-UP; EARLY REBLEEDING RATE; N-NITROSO COMPOUNDS;
D O I
10.1136/gutjnl-2012-302084
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.
引用
收藏
页码:646 / 664
页数:19
相关论文
共 329 条
[71]  
Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680
[72]   Meta-analysis:: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori [J].
Fischbach, L. ;
Evans, E. L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) :343-357
[73]   S3-Guideline "Helicobacter pylori and gastroduodenal ulcer disease" of the German Society for Digestive and Metabolic Diseases (DGVS) in cooperation with the German Society for Hygiene and Microbiology, Society for Pediatric Gastroenterology and Nutrition e.V., German Society for Rheumatology, AWMF-Registration-no. 021/001 [J].
Fischbach, W. ;
Malfertheiner, P. ;
Hoffmann, J. C. ;
Bolten, W. ;
Bornschein, J. ;
Goetze, O. ;
Hoehne, W. ;
Kist, M. ;
Koletzko, S. ;
Labenz, J. ;
Layer, P. ;
Miehlke, St. ;
Morgner, A. ;
Peitz, U. ;
Preiss, J. ;
Prinz, C. ;
Rosien, U. ;
Schmidt, W. ;
Schwarzer, A. ;
Suerbaum, St. ;
Timmer, A. ;
Treiber, G. ;
Vieth, M. .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (12) :1230-1263
[74]   Clinical implications of E-cadherin associated hereditary diffuse gastric cancer [J].
Fitzgerald, RC ;
Caldas, C .
GUT, 2004, 53 (06) :775-778
[75]   Asia-Pacific consensus guidelines on gastric cancer prevention [J].
Fock, Kwong Ming ;
Talley, Nick ;
Moayyedi, Paul ;
Hunt, Richard ;
Azuma, Takeshi ;
Sugano, Kentaro ;
Xiao, Shu Dong ;
Lam, Shiu Kum ;
Goh, Khean Lee ;
Chiba, Tsutomu ;
Uemura, Naomi ;
Kim, Jae G. ;
Kim, Nayoung ;
Ang, Tiing Leong ;
Mahachai, Varocha ;
Mitchell, Hazel ;
Rani, Abdul Aziz ;
Liou, Jyh Ming ;
Vilaichone, Ratha-Korn ;
Sollano, Jose .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (03) :351-365
[76]   Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients [J].
Ford, A. C. ;
Delaney, B. C. ;
Forman, D. ;
Moayyedi, P. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)
[77]   A community screening program for Helicobacter pylori saves money:: 10-year follow-up of a randomized controlled trial [J].
Ford, AC ;
Forman, D ;
Bailey, AG ;
Axon, ATR ;
Moayyedi, P .
GASTROENTEROLOGY, 2005, 129 (06) :1910-1917
[78]  
Ford Alex, 2003, Can J Gastroenterol, V17 Suppl B, p36B
[79]   Epidemiology of Helicobacter pylori Infection and Public Health Implications [J].
Goh, Khean-Lee ;
Chan, Wah-Kheong ;
Shiota, Seiji ;
Yamaoka, Yoshio .
HELICOBACTER, 2011, 16 :1-9
[80]   Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis [J].
Ford, Alexander C. ;
Malfertheiner, Peter ;
Giguere, Monique ;
Santana, Jose ;
Khan, Mostafizur ;
Moayyedi, Paul .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (48) :7361-7370